Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Aya Asano"'
Autor:
Aya Asano, Shigeto Ueda, Ichiei Kuji, Tomohiko Yamane, Hideki Takeuchi, Eiko Hirokawa, Ikuko Sugitani, Hiroko Shimada, Takahiro Hasebe, Akihiko Osaki, Toshiaki Saeki
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-8 (2018)
Abstract Background Hypoxia is a key driver of cancer progression. We evaluated the prognostic impact of 18F-fluoromisonidazole (FMISO) prior to treatment in patients with breast cancer. Methods Forty-four patients with stage II/III primary breast ca
Externí odkaz:
https://doaj.org/article/71ea1e4447a34fafa8bdccd6ca52018a
Autor:
Aya Asano, Shigeto Ueda, Ichiei Kuji, Tomohiko Yamane, Hideki Takeuchi, Eiko Hirokawa, Ikuko Sugitani, Hiroko Shimada, Takahiro Hasebe, Akihiko Osaki, Toshiaki Saeki
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-2 (2018)
After the publication of this article [1], we noticed that in Fig. 2, the survival curve images (C and D, lower panel) were incorrect. The corrected Fig. 2 is presented below. The correction does not affect in any our results and conclusions.
Externí odkaz:
https://doaj.org/article/32f8fae334f14113a2ad4047e4e5acad
MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2
Autor:
Tomomi Fujii, Keiji Shimada, Aya Asano, Yoshihiro Tatsumi, Naoko Yamaguchi, Masaharu Yamazaki, Noboru Konishi
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 8, p 1351 (2016)
Aberrant expression of microRNAs (miRNAs) is involved in the development and progression of various types of cancers. In this study, we investigated the role of miR-331-3p in cell proliferation and the expression of keratinocyte differentiation marke
Externí odkaz:
https://doaj.org/article/9ba442260f2343669d301cbc7fc7f7e0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
KAZUO MATSUURA, AKIHIKO OSAKI, YUKI ICHINOSE, AKIHIRO FUJIMOTO, AYAKA SAKAKIBARA, ASAMI NUKUI, HIDEKI YOKOGAWA, HIROKO SHIMADA, AYA ASANO, MASAHIRO OHARA, HIROSHI ISHIGURO, TAKAO TAKAHASHI, TOSHIAKI SAEKI
Publikováno v:
Oncology Letters; Nov2023, Vol. 26 Issue 5, p1-6, 6p
Background Eribulin is widely used in treating metastatic breast cancer (BC). Higher neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte ratios (PLR) are associated with higher mortality in several cancers. However, the association between BC p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12aa5b97099b3475cb6fac18415a31aa
https://doi.org/10.21203/rs.3.rs-1724372/v1
https://doi.org/10.21203/rs.3.rs-1724372/v1
Autor:
Takumi Gohara, Hironobu Yonekawa, Kazuko Obana, Takahiro Hasebe, Keisuke Ishizawa, Tetsuro Kodaka, Takaki Emura, Makoto Komura, Toshiaki Saeki, Kan Terawaki, Chih-Ping Li, Hiroaki Komuro, Atsushi Sasaki, Hitoshi Tsuda, Aya Asano, Akihiko Osaki, Toru Kikuchi
Publikováno v:
Breast Cancer. 27:785-790
Secretory breast carcinoma constitutes the majority of breast cancers in children and young people less than 20 years of age. Noninvasive examination is particularly necessary for the diagnosis of breast carcinoma in children. Herein, we report a cas
Autor:
Yuki, Ichinose, Takashi, Hojo, Akihiro, Fujimoto, Asami, Nukui, Hiroko, Shimada, Hiroshi, Sano, Hideki, Yokogawa, Kazuo, Matsuura, Aya, Asano, Takahiro, Hasebe, Akihiko, Osaki, Toshiaki, Saeki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(9)
Occult breast cancer is rare in practice. We studied the clinical outcomes of 5 occult breast cancers, including 2 with Luminal and 3 with non-Luminal subtypes, for which the primary site was not detected in the breast-by-breast MRI. The percentage o
Autor:
Tomonori Kawasaki, Hiroko Shimada, Kazuo Matsuura, Asami Nukui, Miyuki Hiratsuka, Akihiro Fujimoto, Aya Asano, Akihiko Osaki, Yuki Ichinose, Toshiaki Saeki
Publikováno v:
Oxford Medical Case Reports
Breast cancer arising from fibroadenoma (FA) is rare, in which almost all reported cases are human epidermal growth factor receptor 2 (HER2)-negative. This is the first report to describe a case of HER2-positive breast cancer arising from FA that was
Autor:
Yuki Ichinose, Hiroko Shimada, Kazuo Matsuura, Toshiaki Saeki, Yoshimasa Kosaka, Takahiro Hasebe, Akihiro Fujimoto, Asami Nukui, Aya Asano, Akihiko Osaki
Publikováno v:
Journal of Surgical Case Reports
Granulomatous mastitis is a rare breast disease that is categorized as a benign tumor with chronic inflammation. Since the cause of the chronic inflammation is usually unknown, it is sometimes called idiopathic granulomatous mastitis (IGM). Although